From: Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
HepG2 cell | HepG2 fatty cell | rimonabant/HepG2 fatty cell | F value | P value | ||
---|---|---|---|---|---|---|
SREBP-1C | 0. 2267 ± 0. 2517 | 0. 9200 ± 0. 2646 | 0. 1233 ± 0. 2517 | 858. 864 | 0. 000 | p < 0.05 |
ACC1 | 0. 1100 ± 0. 0100 | 0. 5533 ± 0. 0503 | 0. 0433 ± 0. 0208 | 225. 533 | 0. 000 | p < 0.05 |
ChREBP | 0. 1233 ± 0. 0251 | 0. 7533 ± 0.0503 | 0. 1433 ± 0. 0208 | 320. 583 | 0. 000 | p < 0.05 |
LPK | 0. 2567 ± 0. 0450 | 0. 2267 ± 0. 0450 | 0. 2267 ± 0. 0288 | 0. 551 | 0. 000 | p > 0.05 |
LXRs | 0. 1367 ± 0. 0321 | 0. 4500 ± 0. 0500 | 0. 0400 ± 0. 0173 | 107. 852 | 0. 000 | p < 0.05 |
RXR | 0. 5933 ± 0. 0416 | 0. 5233 ± 0. 1069 | 0. 5700 ± 0. 0755 | 0. 606 | 0. 576 | p > 0.05 |